Universitätsklinikum Essen

VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AML (2025) Kretschmer L, Ruhnke L, Schliemann C, Fransecky L, Steffen B, Kaufmann M, Burchert A, et al. Journal article Paediatric acute liver failure: A prospective, nationwide, population-based surveillance study in Germany (2025) Lenz D, Abdulaziz M, Peters B, Wagner M, Schlieben LD, Corman VM, Baumann U, et al. Journal article The SmartNTx-study: a prospective, randomized controlled trial to investigate additional interventional telemedical management versus standard aftercare in kidney transplant recipients (2025) Schiffer M, Pape L, Wolff JK, Gertges R, Visconti V, Reichert K, Pfau A, et al. Journal article Physical activity and exercise performance in patients after kidney transplantation – Data from the prospective KTx360° aftercare program (2025) Pape L, Boeck HT, Boyen J, Nöhre M, Schiffer L, Kück M, Schieffer E, et al. Journal article Guideline-recommended basic parameter adherence in neurocritical care stroke patients: Observational multicenter individual participant data analysis. (2025) Mrochen A, Alhaj Omar O, Pelz JO, Michalski D, Neugebauer H, Lehrieder D, Knier B, et al. Journal article Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis (2025) Ronnacker J, Muller PJ, Mikesch JH, Zukunft S, Weinbergerová B, Šrámek J, Valka J, et al. Journal article [68Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial (2025) Pabst KM, Weber MM, Laschinsky C, Sandach P, Bartel T, Küper AT, Kessler L, et al. Journal article Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral Sclerosis (2025) Steffke C, Baskar K, Bachhuber F, Wiesenfarth M, Dorst J, Schuster J, Schöberl F, et al. Journal article Was sind Wundbeläge? Ein Positionspapier der Initiative Chronische Wunden (ICW) e. V. (2025) Dissemond J, Erfurt-Berge C, Gerber V, Motzkus M, Teubner K, Rembe JD Journal article Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma. (2025) Wolchok JD, Chiarion-Sileni V, Rutkowski P, Cowey CL, Schadendorf D, Wagstaff J, Queirolo P, et al. Journal article